ArticleBMJ open2023

Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn's disease (CD): protocol of a pilot study.

Charlotte M Verburgt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.